As cell models, we used several breast cancer cell lines, including two TNBCs (i.e., MDA-MB-231 and SUM159), a HER2-enriched breast cancer cell line (SK-BR-3), and a cell line representative of the molecular subtype Luminal A (i.e., T47D). This evidence concerns the gene ERBB2 and breast carcinoma.